Form 8.3 - Horizon Therapeutics plc

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	1^st August 2023

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,310,595 (1.883%)		-
(2) Derivatives (other than options)	511,000 (0.223%)		511,000 (0.223%)
(3) Options and agreements to purchase/sell	1,789,200 (0.782%)		2,242,200 (0.979%)
Total	6,610,795 (2.888%)		2,753,200 (1.203%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
Purchase	100	99.54
Purchase	400	99.81
Purchase	918	99.97
Purchase	100	99.51
Sale	29	100.17
Purchase	200	99.91
Purchase	7,153	100.00
Purchase	200	99.67
Purchase	3,959	99.99
Purchase	550	99.85
Purchase	100	99.49
Purchase	200	99.57
Purchase	60	99.31
Purchase	300	99.95
Purchase	100	99.90
Purchase	100	99.88
Purchase	100	99.93
Purchase	300	99.86
Purchase	100	99.56
Purchase	100	99.50
Purchase	200	99.98
Purchase	300	99.68
Purchase	200	99.94
Purchase	600	99.83
Purchase	500	99.87
Purchase	200	99.71
Purchase	100	99.89
Purchase	96	99.74
Purchase	300	99.92
Purchase	800	99.80
Purchase	200	99.79
Purchase	300	99.96
Purchase	293	99.77
Purchase	100	99.75
Purchase	237	99.70
Purchase	234	99.82
Purchase	29	99.69
Purchase	200	99.66
Purchase	100	99.65
Purchase	30	99.97
Purchase	178	99.91
Purchase	33	100.04
Purchase	12	100.00
Purchase	5	99.67
Purchase	15	99.99
Purchase	166	100.07
Purchase	153	99.95
Purchase	340	100.08
Purchase	10	99.76
Purchase	34	99.86
Purchase	12	100.02
Purchase	24	100.10
Purchase	286	100.12
Purchase	17	100.01
Purchase	22	99.94
Purchase	77	99.83
Purchase	8	99.87
Purchase	392	100.11
Purchase	153	100.06
Purchase	3	100.13
Purchase	32	99.79
Purchase	3	99.75
Purchase	85	99.78
Purchase	99	99.82
Sale	2,053	99.69
Purchase	986	99.81
Sale	586	99.81
Purchase	26	99.97
Purchase	302	99.91
Purchase	31	100.04
Purchase	101	100.00
Purchase	1,004	99.52
Purchase	112	99.67
Purchase	6	99.58
Purchase	100	99.85
Purchase	100	100.05
Purchase	236	100.07
Purchase	4	99.49
Purchase	1,040	99.90
Purchase	167	100.08
Purchase	87	99.88
Purchase	250	99.76
Purchase	22	99.93
Purchase	513	99.86
Purchase	204	100.02
Purchase	1,100	100.10
Purchase	117	100.12
Purchase	1	100.01
Purchase	8	99.98
Purchase	8	99.68
Purchase	9	99.94
Purchase	17	100.23
Purchase	25	99.83
Sale	73	99.83
Purchase	315	100.15
Purchase	812	100.09
Purchase	18	100.11
Purchase	419	100.06
Purchase	83	100.21
Purchase	3	99.55
Purchase	8	99.64
Purchase	27	100.03
Purchase	16	100.13
Purchase	199	100.14
Purchase	3	100.16
Purchase	1	99.92
Purchase	4,748	99.80
Purchase	2	99.77
Purchase	235	99.78
Sale	100	99.78
Purchase	98	99.70
Purchase	45	99.82
Purchase	801	99.69
Purchase	1	99.84
Sale	240	100.04

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (USD) (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price (USD)	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
Call Option	Purchased	200,000	115.00	American	8/18/2023
Put Option	Purchased	80,600	100.00	American	8/18/2023
Call Option	Purchased	700	110.00	American	1/19/2024
Call Option	Selling	17,200	115.00	American	1/19/2024
Put Option	Selling	83,100	95.00	American	8/18/2023
Put Option	Selling	1,500	60.00	American	12/15/2023
Put Option	Selling	16,500	45.00	American	1/19/2024
Put Option	Purchased	16,500	65.00	American	1/19/2024

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	2^nd August 2023
Contact name	Stephen Glasper
Telephone number	[phone]
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	100,300	90.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	1,200	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	1,200	115.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	50,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	29,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	250,000	85.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	119,400	110.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	4,500	110.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	100,000	100.00	American	12/15/2023
IE00BQPVQZ61	Call Option	Written	100,000	110.00	American	12/15/2023
IE00BQPVQZ61	Put Option	Purchased	100,000	85.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	2,800	100.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	2,800	100.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Written	50,000	85.00	American	15/09/2023
IE00BQPVQZ61	Put Option	Purchased	150,000	85.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Purchased	2,600	90.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Purchased	40,900	100.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	200	100.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	200	100.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	100,000	70.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	300	100.00	American	15/09/2023
IE00BQPVQZ61	Put Option	Purchased	300	100.00	American	15/09/2023
IE00BQPVQZ61	Put Option	Written	100,000	60.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Written	16,900	110.00	American	15/09/2023
IE00BQPVQZ61	Call Option	Purchased	535,200	110.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Written	554,700	115.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	476,900	95.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	546,500	60.00	American	12/15/2023
IE00BQPVQZ61	Put Option	Written	100,000	65.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Purchased	55,000	70.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Written	200,000	105.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	41,500	45.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Written	66,900	100.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	41,500	65.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	47,500	101.00	American	8/4/2023
IE00BQPVQZ61	Call Option	Purchased	11,400	100.00	American	8/11/2023
IE00BQPVQZ61	Call Option	Purchased	11,400	101.00	American	8/11/2023
IE00BQPVQZ61	Put Option	Purchased	9,600	100.00	American	8/11/2023
IE00BQPVQZ61	Put Option	Purchased	9,600	101.00	American	8/11/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1150905

Time of Receipt (offset from UTC): 20230802T143706+0100